A short while ago Evmedreview commissioned Joe Alcock to write a series of monthly op-ed columns. This is the first. In due course it will be moved to the new Op-Ed page in the updated evmedreview.com website. The Editors. The pharmaceutical company was Eisai, a Japanese firm. The drug was eritoran, an investigational […]
from The Evolution and Medicine Review http://ift.tt/2dC3qGw
No comments:
Post a Comment